Raymond Ruff

Science TLDR

Science EN ↓ 94 episodes

Ten-minute paper summaries for scientists and experts. Two episodes a week: Mondays feature the top-scoring paper from a curated weekly digest of T cell engager, bispecific antibody, and protein engineering literature. Fridays cover the top trending paper on PubMed — any field, whatever's catching the research community's attention that week. Hosted by Raymond Ruff, a protein scientist working in translational immunotherapeutics. Audio is generated with NotebookLM; the host prompt aims for measured scientific skepticism rather than hype. Feedback and paper suggestions: sciencetldrpod@gmail.com

Be sure to visit the podcast's website and support the creator: raymondruff.github.io

Author

Raymond Ruff

Category

Science

Podcast website

raymondruff.github.io

Latest episode

Oct 19, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android almost 10M downloads · 4.8 rating iOS soon

Episodes

Accelerated enzyme engineering by machine-learning guided cell-free expression 23.01.2025

DOI: https://doi.org/10.1038/s41467-024-55399-0 Central Idea: This paper presents an ML-guided platform for accelerating enzyme engineering by combining cell-free protein synthesis, functional screening, and machine learning to rapidly optimize enzymes for multiple distinct chemical reactions. The approach is demonstrated by engineering variants of an amide synthetase (McbA) to improve synthesis o...

Discovery of a new class of cell‑penetrating peptides by novel phage display platform 17.01.2025

DOI: 10.1038/s41598-024-64405-w Central Idea: Researchers developed a novel phage display platform called NNJA (Novel peptides for intracellular delivery by hijacking two cell systems) that discovers cell-penetrating peptides capable of delivering therapeutic cargo to the cell cytoplasm while avoiding lysosomal degradation. This platform addresses a major challenge in the field of therapeutic deli...

Learning the language of antibody hypervariability 16.01.2025

DOI: 10.1073/pnas.2418918121 Central Idea: This paper introduces AbMAP (Antibody Mutagenesis-Augmented Processing), a novel transfer learning framework that adapts foundational protein language models (PLMs) specifically for antibody analysis. The key innovation is focusing on hypervariable regions (CDRs) while leveraging the broader protein knowledge from foundational models, achieving superior p...

System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans 13.01.2025

DOI: 10.1038/s41590-024-02036-z Central Idea: This study reveals how platelets and their precursor cells (megakaryocytes) influence the durability of vaccine-induced antibody responses. The researchers identified a platelet-associated signature that predicts how long antibody responses will last across multiple vaccine types and discovered a mechanism involving megakaryocytes supporting plasma cel...

Recombinant venom proteins in insect seminal fluid reduce female lifespan 12.01.2025

DOI: https://doi.org/10.1038/s41467-024-54863-1 Central Idea: Researchers developed a new genetic biocontrol technique called the "Toxic Male Technique" (TMT) where engineered male insects express venom proteins in their reproductive tract that reduce female lifespan after mating. This represents a paradigm shift from traditional genetic biocontrol methods by affecting females within the same gene...

Autonomous mobile robots for exploratory synthetic chemistry 15.11.2024

DOI : 10.1038/s41586-024-08173-7 Central Idea : This paper presents a modular autonomous chemical synthesis platform integrating mobile robots, a Chemspeed ISynth synthesizer, UPLC-MS, and benchtop NMR, enabling automated experimentation and heuristic decision-making for exploratory synthesis. This approach mimics human workflows by using orthogonal characterization data and is applicable to diver...

A mechanism for hypoxia-induced inflammatory cell death in cancer 14.11.2024

DOI: 10.1038/s41586-024-08136-y Central Idea: This paper elucidates a novel mechanism for hypoxia-induced inflammatory cell death in cancer, specifically pyroptosis, mediated by a PTP1B-RNF213-CYLD-SPATA2 pathway. This pathway presents potential therapeutic targets for resistant hypoxic tumors. Key Concepts: Hypoxia and Cancer: Hypoxia within the tumor microenvironment promotes resistance to thera...

Coordinated inheritance of extrachromosomal DNAs in cancer cells 13.11.2024

DOI : 10.1038/s41586-024-07861-8 Central Idea : This paper investigates the coordinated inheritance of extrachromosomal DNAs (ecDNAs) in cancer cells, revealing that distinct ecDNA species co-segregate during mitosis, influenced by intermolecular interactions and transcription. This coordinated inheritance impacts oncogene co-amplification, ecDNA specialization, and responses to targeted therapy....

Decomposing causality into its synergistic, unique, and redundant components 03.11.2024

DOI : 10.1098/rsta.2021.0150 Central Idea: This paper introduces SURD (Synergistic-Unique-Redundant Decomposition), a novel framework for quantifying causality by decomposing it into its synergistic, unique, and redundant components based on information theory. SURD overcomes limitations of existing causal inference methods, especially in complex systems with nonlinear dependencies, stochasticity,...

Probiotic neoantigen delivery vectors for precision cancer immunotherapy 25.10.2024

Authors: Redenti et al. DOI: 10.1038/s41586-024-08033-4 Central Idea: This study engineers a probiotic E. coli Nissle 1917 strain to deliver tumor-specific neoantigens, creating a potent in situ cancer vaccine. This engineered probiotic effectively stimulates anti-tumor immunity and controls or eliminates tumor growth in mouse models of colorectal cancer and melanoma. Key Concepts: Neoantigen-base...

Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies 22.10.2024

Authors: Kapetanovic et al. DOI: 10.1038/s41551-024-01255-x Central Idea: This study demonstrates a method to engineer allogeneic T cells that are unresponsive to their native target antigen, thereby reducing the risk of graft-versus-host disease (GvHD), while retaining their ability to be activated by bispecific antibodies (biAbs) for cancer immunotherapy. These "Allogeneic-Engineered-Decoupled"...

The hallmarks of cancer immune evasion 18.10.2024

Review: The Hallmarks of Cancer Immune Evasion DOI: 10.1016/j.ccell.2024.09.010 Claudia Galassi, Timothy A. Chan, Ilio Vitale & Lorenzo Galluzzi Central Idea: This review proposes a "Three Cs" framework (Camouflage, Coercion, and Cytoprotection) to categorize the diverse mechanisms cancer cells utilize to evade the immune system. Key Concepts: Camouflage: Hiding from immune detection. Downregu...

In vivo dendritic cell reprogramming for cancer immunotherapy 10.10.2024

DOI: 10.1126/science.adn9083 This episode delves into a novel approach to cancer immunotherapy: in vivo reprogramming of tumor cells into type 1 conventional dendritic cells (cDC1s) using the transcription factors PU.1, IRF8, and BATF3 (PIB). Key Findings: PIB overexpression reprograms tumor cells into cDC1-like cells in vivo, inducing robust, systemic antitumor immunity in mouse melanoma models....

Osr2 functions as a biomechanical checkpoint to aggravate CD8+ T cell exhaustion in tumor 11.07.2024

This episode explores groundbreaking research that uncovers a novel link between the mechanical properties of the tumor microenvironment and CD8+ T cell exhaustion, a major hurdle for effective cancer immunotherapy. Key Findings: Stiffer tumor regions, rich in collagen, harbor a higher proportion of exhausted CD8+ T cells. Mechanical stress, mimicked by culturing T cells on stiff matrices or using...

Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy 15.05.2024

Reference PMID: 38723627 This episode explores groundbreaking research demonstrating that the efficacy of cancer immunotherapy is influenced by the time of day of administration, highlighting the critical role of circadian rhythms in shaping anti-tumor immune responses. Key Findings: The number of tumor-infiltrating leukocytes (TILs) in melanoma tumors oscillates throughout the day, peaking in the...

ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion 23.04.2024

This episode delves into a fascinating study that uncovers a novel immune checkpoint molecule, ITPRIPL1, and its role in suppressing T cell activation and enabling tumor immune evasion. Key Findings: ITPRIPL1, a protein normally enriched in the testes, is overexpressed in various human cancers, particularly those with low or no PD-L1 expression. ITPRIPL1 directly binds to CD3ε, a component of the...

Neutrophil profiling illuminates anti-tumor antigen-presenting potency 20.03.2024

This episode explores a groundbreaking study that unveils the remarkable diversity and potential of neutrophils in cancer immunotherapy. Key Findings: Researchers identified 10 distinct neutrophil states within the tumor microenvironment, including an antigen-presenting state characterized by HLA-DR expression. HLA-DR+ neutrophils can effectively present tumor neoantigens and activate T cell respo...

Immunoinformatics Approach to Design a Chimeric CD70-Peptide Vaccine against Renal Cell Carcinoma 20.03.2024

This episode dives into a promising study utilizing immunoinformatics to design a novel vaccine against Renal Cell Carcinoma (RCC), a prevalent and deadly form of kidney cancer. Key Findings: Researchers identified multiple immunogenic epitopes within the CD70 protein, a molecule overexpressed in RCC. These epitopes were carefully selected based on their antigenicity, non-allergenicity, and non-to...

Sequence clustering confounds AlphaFold2 26.02.2024

Main Topic: A critical evaluation of AF-cluster, a method used to predict the structures of metamorphic proteins with AlphaFold2 (AF2). Key Points: Metamorphic proteins can adopt multiple stable conformations, making their structure prediction challenging. AF-cluster, initially presented as a solution, is called into question by Schafer et al. due to: Inaccurate predictions compared to random samp...

Listen to the Science TLDR podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.